Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
- 29 February 2012
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 62 (2), 978-987
- https://doi.org/10.1016/j.neuropharm.2011.10.003
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the ratBioorganic & Medicinal Chemistry Letters, 2010
- Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Hypocretins in the Control of Sleep and WakefulnessCurrent Neurology and Neuroscience Reports, 2010
- Proline bis-amides as potent dual orexin receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2008
- Promotion of sleep by targeting the orexin system in rats, dogs and humansNature Medicine, 2007
- Orexin A in the VTA Is Critical for the Induction of Synaptic Plasticity and Behavioral Sensitization to CocaineNeuron, 2006
- Diagnosis and Treatment of Chronic Insomnia: A ReviewPsychiatric Services, 2005
- Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severityExperimental Neurology, 2004
- Narcolepsy in orexin Knockout Mice: Molecular Genetics of Sleep RegulationCell, 1999
- Guidelines for the Rational Use of BenzodiazepinesDrugs, 1994